The TLR2/6 ligand PAM2CSK4 is a Th2 polarizing adjuvant in Leishmania major and Brugia malayi murine vaccine models
Crossref DOI link: https://doi.org/10.1186/s13071-016-1381-0
Published Online: 2016-02-20
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Halliday, Alice
Turner, Joseph D.
GuimarĂ£es, Ana
Bates, Paul A.
Taylor, Mark J.
Funding for this research was provided by:
Biotechnology and Biological Sciences Research Council (CASE award (Pfizer))